CI

At a glance

ClinicalIndex Comparison Record
Phase 1Recruiting· 150 target
Drug / intervention
Topical herbal plasterdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07447856
NCT07447856Phase 1RecruitingHigh MomentumUpdated 3mo ago
CompareCT.gov

Integrating Topical Herbal Plasters to Enhance Pain Management and Reduce Opioid Use in Cancer Patients (EASE)

Memorial Sloan Kettering Cancer Center·interventional·Posted Mar 4, 2026·Updated Mar 4, 2026

In Brief

A Phase 1 clinical trial evaluating Topical herbal plaster for Cancer Patients and 2 related conditions. Currently recruiting, targeting 150 participants across 7 sites.

Signals

Enrolling ahead of pace

Detailed Summary

The are doing this study to find out whether using topical (on the skin) herbal plasters, Tibetree pain- relieving plasters (PRPs), can be an effective addition to standard opioid therapy for pain management. The researchers will look at whether the Tibetree PRPs are a practical (feasible) and effective way of managing localized pain (pain that is limited to a certain area) in people who are currently taking opioids. Participants in this study will have cancer or have had it in the past.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer Patients, Survivor Patients, Cancer Pain
CountriesUnited States
Collaborators--

Timeline

Phase 1Recruiting
20272028
First PostedMar 4, 2026
Enrollment StartFeb 23, 2026
Primary CompletionFeb 1, 2028
TodayJul 1, 2026
Enrollment to primary: 1.9 yearsPosted 4 months agoPrimary completion in 1.6 years

Interventions

Topical herbal plasterdrug

Participants will receive topical herbal plaster once a day for up to 8 hours daily for 7 days.